Research from Adelaide University indicates that daily probiotic supplementation could improve gut and skin health in dogs, potentially reducing skin infections.
Recent advancements in protein engineering may improve cancer therapies. Proteases, enzymes that act as molecular scissors, are crucial in developing treatments that target both viral replication and cancer cell destruction.
A closer look at the ongoing disputes surrounding drug price transparency and the role of pharmacy benefit managers (PBMs) in this contentious issue.
As Brighton gears up to take on Chelsea, the focus is on Joao Pedro's late fitness test, which could impact the match's outcome.
Recent developments highlight significant progress in targeting KRAS, a key player in cancer treatment, alongside other notable biotech news including the Breakthrough Prize winners.
In recent pharmaceutical news, Trump has shown support for psychedelic treatment options while discussions continue regarding the future of weight-loss drugs.
Recent discussions highlight the effects of cannabis on adolescent brain development, alongside updates on the CDC director nominee and a measles outbreak.
Recent findings suggest that prolonged use of a drug from Nektar Therapeutics may encourage hair growth in individuals suffering from alopecia.
Theonila Roka Matbob, a Goldman Prize winner, emphasizes the role of women as guardians of the land while addressing the damage caused by mining in Papua New Guinea.
Pharmacy benefit managers (PBMs) are opposing a significant proposal aimed at increasing transparency in drug pricing, claiming it may be illegal.
On the 10th anniversary of Victoria Wood's death, friends and fans reflect on her remarkable talent and the impact she had on the world of comedy.
The American Association of Cancer Researchers' annual meeting showcases significant advancements in the development of KRAS-targeting therapies, particularly by Revolution Medicines.
Early retirement at 62 can be appealing, but it comes with significant financial considerations, including a $47,000 healthcare gap before Medicare starts.
Zai Lab and Amgen have announced a partnership to evaluate a new approach to lung cancer treatment, marking a significant step in cancer research.
The FDA has accepted Ultragenyx's Biologics License Application for its gene therapy UX111, aimed at treating Sanfilippo Syndrome.
As school choice initiatives gain traction in Iowa and nationwide, Cedar Rapids serves as a case study on the potential impacts of market-driven education.
Despite a notable increase in Medicare Advantage spending in Puerto Rico, the expected improvements in plan quality have not materialized.
The latest issue of Health Affairs delves into critical topics such as drug pricing strategies, the role of behavioral health, and hospital policies.
The first year of the ACO program aimed at enhancing equity and community health has shown promising results, according to Health Affairs.
A recent analysis explores how changing patient cost-sharing practices are affecting the financial stability of both urban and rural hospitals.